+1-888-308-5802     
News Contact Us

Lyndra Therapeutics to develop ‘once-a month’ birth control pills

Author : Shikha Sinha | Published Date : 2019-07-31 
  • The company has received a grant of USD 13 Million from the Bill and Melinda Gates Foundation.
  • This grant focuses upon meeting the unmet therapeutic needs for women health.

Lyndra Therapeutics, the company that has literally rendered daily pills obsolete, has reportedly announced receiving a USD 13 million grant from the Bill & Melinda Gates Foundation for the development of an oral contraceptive which is expected to last for over a month.

As per the authentic sources, the endowment is a part of the Bill and Melinda Gates Family Planning program, which is currently working on providing access to high-quality contraceptive information, facilities and supplies to women in low- and middle-income countries.

According to the industry experts nearly 214 mn women of reproductive age in developing regions are avoiding the use of contraceptives as of 2017. Amongst the estimated 206 million pregnancies reported in 2017 in the developing nations, 43% were unplanned, and the care expenses related to these pregnancies approximately adds up to USD 8.3 billion yearly.

Amy Schulman, CEO & co-creator of Lyndra Therapeutics was reportedly quoted stating that the 13-million-dollar grant was special to the company as it extends their focus on addressing the unmet therapeutic needs into women health. The company is also gratified to be associated with the Bill and Melinda Gates Foundation’s attempts to improve the lives of women and ensure proper health conditions.

Reportedly, with the funds collected, Lyndra is currently designing and structuring a new once-a month oral combination therapy that produces a continuous dosage of estrogen and progestin, which are used in everyday combined oral contraceptives. The development program is focused on demonstrating that once-monthly residence is achievable which includes preclinical evaluation conducted in collaboration with a non-profitable social and public health research organization- Routes2Results with extensive regional expertise, through additional funding from the foundation.

Headquartered in USA, Lyndra Therapeutics aims to advance the healthcare outcomes through oral therapies that change the way people take medicines.

Source credit: https://finance.yahoo.com/news/lyndra-therapeutics-develop-once-monthly-040100614.html

About Author

Shikha Sinha

Shikha Sinha

Shikha Sinha currently pens down content for fractovia.org, a news platform which provides the latest business highlights and industry trends. Shikha also is a contributor on various other online media websites where she writes informative, research-oriented content spanning the retail, healthcare, F&B, and technology sectors. As her first stint in writing, Shikha was an active contributor on Yahoo Voices where she penned down creative and imaginative pieces. She holds a Bachelor of Technology degree in Electrical and Electronics Engineering. She can be contacted at- [email protected] | https://twitter.com/shikhas999

Related News

Clio raises $250 million in a Series D funding by TCV and JMI Equity

Published Date: 2019-09-06         Author: Shikha Sinha

The cloud-based legal technology startup hits a historic mark in future of legal industry with this investment. Clio, a leading legal software company has recently announced that it has bagged US$250 million in Series D funding from American equity firms JMI Equity and TCV. According to sour... Read More

Co-working firm Spacious the latest in WeWork’s acquisition spree

Published Date: 2019-08-29         Author: Shikha Sinha

New York-based co-working business, The We Company, formerly known as WeWork, has today announced its acquisition of rival start-up Spacious. The company, formed three years ago, is focused on converting restaurants closed during the day into efficient spaces for co-working. WeWork is a part of many... Read More

SoftBank in talks to invest $150M in Dailyhunt and $400M in Lenskart

Published Date: 2019-08-27         Author: Shikha Sinha

SoftBank is expected to lead a $250 million round with private equity major Carlyle for Dailyhunt   South American conglomerate Synergy Group also hopes to invest in India’s Jet Airways. SoftBank Group Corp., a Japanese multinational conglomerate, is reportedly in talks to clo... Read More

© 2020 Fractovia. All Rights Reserved